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TO THE EDITOR
Organ transplant recipients have a 100-
fold increased risk of developing
cutaneous squamous cell carcinoma
(SCC) compared to the general popula-
tion (Euvrard et al., 1993). Compared to
immunocompetent patients, organ
transplant recipients often develop
more invasive and aggressive SCCs,
with increased multiplicity, recurrence,
and risk for metastasis. In addition to
SCCs, organ transplant recipients
develop more keratoacanthomas (KAs),
Bowen’s disease, and actinic keratoses.
A potential reason for the development
of these tumors is that posttransplant
immunosuppressive medications result
in enhanced susceptibility to infection.
Histologically, many of the lesions in
these patients demonstrate the hall-
marks of viral infection such as the
presence of koilocytes and verruciform
epidermal hyperplasia (Euvrard et al.,
1993; Hsi et al., 1997; Harwood et al.,
2006).
Study of viruses in skin tumors of
transplant patients has previously fo-
cused on human papilloma virus (HPV).
PCR assays for epidermodysplasia ver-
ruciformis and mucosal serotypes of
HPV have revealed that high risk
mucosal HPVs are relatively infrequent
in these cutaneous tumors. The fre-
quency of epidermodysplasia verruci-
formis HPV infection ranges from
39–92% in SCCs from transplant pa-
tients (Berkhout et al., 1995; Boxman
et al., 1997; Hopfl et al., 1997).
However, the presence of epidermo-
dysplasia verruciformis HPV can also
be found in plucked hairs and forehead
swabs from healthy individuals and skin
tumors from immunocompetent pa-
tients (Boxman et al., 1997; Hsi et al.,
1997; McGregor et al., 1997; Hazard
et al., 2007). Thus, the exact etiologic
role that these viruses play in skin
cancer in organ transplant recipients
remains unclear. Other viruses may
also contribute to tumorigenesis in
organ-transplant patients. Recently, the
presence of polyomavirus has been
detected in 80% of Merkel cell carci-
nomas (MCCs; Feng et al., 2008). In
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Figure 1. MCPyV is more prevalent in patients with metastatic disease. The percentage of MCPyV
absence is given for patients without (primary tumor only) and with (metastasis) known metastatic
disease. The inset depicts representative results for presence (patient BE; MCV: black line;
LINE1: black dashed line) and absence (patient SM; MCV gray line; LINE1: gray dotted line) of
MCPyV in two primary tumors. LINE1 serves as DNA control.
Abbreviations: HPV, human papilloma virus; KA, keratoacanthoma; MCC, Merkel cell carcinoma; SCC,
squamous cell carcinoma
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these tumors, two viral genomes,
designated MCV339 and MCV350,
were identified that are distantly related
to the known human polyomaviruses.
Polyomavirus infection in immuno-
competent individuals is harmless.
However, in immunocompromised
individuals, BK virus infection most
often leads to nephropathy whereas JC
polyomavirus infection commonly
causes multifocal leukoencephalopathy
(Drachenberg et al., 2007; Weiner and
Narayan, 1973). MCC is a rare but
potentially aggressive primary neuroen-
docrine carcinoma of the skin that
presents most commonly on sun-ex-
posed areas. Increased incidence is
associated with immunosuppression,
and MCCs are more prevalent in
patients with HIV infection, leukemias,
and organ transplantation (Miller and
Rabkin, 1999; Engels et al., 2002;
Kanitakis et al., 2006; Pectasides
et al., 2007).
To investigate the potential role of
polyomavirus in nonmelanoma skin
cancer and actinic keratoses, we used
the PCR-based assay described by Feng
et al. (2008) to detect the presence of
polyomavirus in 156 nonmelanoma
skin cancers from organ transplant
recipients. The study was approved by
the Institutional Review Board of the
University of California, San Francisco.
The study was conducted according to
the Declaration of Helsinki Principles
and written consent was obtained from
the participants. Genomic DNA was
extracted from formalin-fixed paraffin-
embedded tumors and the DNA
concentration was estimated by Taq-
man analysis (Ginzinger et al., 2000). A
400 base pair fragment of b-globin was
amplified as a positive control to
determine the presence of PCR-amplifi-
able DNA. The PCR assay was vali-
dated on a cohort of MCCs and the
results showed that 54% (7/13) of
tumors were positive for the presence
of polyomavirus. Genomic DNA from a
MCC was used as a positive control in
all subsequent PCR assays. We exam-
ined 85 SCCs, 37 KAs, 28 Bowen’s
disease, and 6 actinic keratoses for the
presence of polyomavirus DNA. Geno-
mic DNA (50 ng) from each tumor was
used to amplify for the LT1, LT3, and
VP1 genomic DNA of the polyomavirus
and the PCR products were separated
on 2% agarose gels. Polyomavirus
fragments were detected in 1 KA
(2.7%). However, the bands were
significantly fainter than in MCCs
(Figure 1). Sequencing of the polyoma-
virus PCR products from the KA re-
vealed that the LT3 and VP1 PCR
products were identical to the
MCV339 virus found in MCC tumors;
whereas the sequence of the LT1 PCR
product differed by 2 base pairs. With
respect to the MCV350 virus, also
detected in MCC tumors, the KA-
derived LT3 product was identical but
the LT1 and VP1 PCR products differed
by 5 and 1 base pairs, respectively. The
presence of polyomavirus in the KA was
not due to contamination because
the viral sequence was different to the
polyomavirus sequences detected in
our cohort of MCC. The pathogenetic
relevance of polyomavirus in this single
KA is unclear.
To conclude, the MCC polyoma-
viruses are an infrequent finding in
nonmelanoma skin cancers of organ
transplant patients.
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Figure 1. Detection of polyomavirus in a single keratoacanthoma. Genomic DNA (50 ng) from a
keratoacanthoma (K) or a Merkel cell carcinoma (MC) were amplified with primers specific for the LT1,
LT3, or VP1 genes of polyomavirus associated with Merkel cell carcinomas (MCCs). N, non template
negative control; M, low mass DNA ladder (fragment length in base pairs is indicated).
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